George Weston Limited
George Weston Limited
George Weston Limited
| Type | Public |
|---|---|
| Traded as | TSX: WN |
| Founded | 1882 |
| Key people | Galen G. Weston (Chairman and CEO) |
| Industry | Retail |
| Revenue | CA$ 48.6 billion (2019) |
| Operating income | CA$ 2.2 billion (2019) |
| Net income | CA$ 1.6 billion (2019) |
| Assets | CA$ 43.2 billion (2019) |
| Equity | CA$ 13.8 billion (2019) |
| Employees | 200,000 (2019) |
| Website | [georgewestonlimited.ca Official website] |
George Weston Limited is a Canadian retail company founded in 1882 by George Weston. It is headquartered in Toronto, Ontario, Canada. The company is publicly traded on the Toronto Stock Exchange under the ticker symbol TSX: WN.
Overview
George Weston Limited operates through its various subsidiaries in the retail industry. The company's primary subsidiary is Loblaw Companies Limited, one of the largest food and pharmacy retailers in Canada. Loblaw operates a network of grocery stores, pharmacies, and other retail outlets across the country.
History
George Weston Limited was established in 1882 by George Weston, who started a bakery in Toronto. Over the years, the company expanded its operations and diversified into various sectors of the retail industry. In 1947, George Weston Limited acquired Loblaw Groceterias, which eventually became its primary subsidiary.
Leadership
The current Chairman and CEO of George Weston Limited is Galen G. Weston. He has been leading the company since 2006 and has played a significant role in its growth and success.
Financial Performance
In 2019, George Weston Limited reported a revenue of CA$
48.6 billion, operating income of CA$ 2.2 billion, and net income of CA$ 1.6 billion. The company's total assets were valued at CA$ 43.2 billion, with equity amounting to CA$ 13.8 billion. As of 2019, George Weston Limited employed approximately 200,000 people.
References
External links
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian